Delving into the Latest Updates on MISSION: CURE INC. with Synapse

Overview

The CZI Rare As One study is a Chan Zuckerberg Initiative funded study that aims to co-design and pilot test unique symptom tracking and transmitting apps across 5 different sub-arms that includes individuals with Long COVID, Pancreatitis, Sarcoidosis, Vasolin-Containing Protein (VCP) disease and Primary Ciliary disease (PCD). This study aims to use multimodal digital health tools to enable patients to self-monitor their symptoms in passive and active ways.

Start Date06 Feb 2025

Sponsor / Collaborator

MISSION: CURE INC.

[+1]

100 Clinical Results associated with MISSION: CURE INC.

Login to view more data

0 Patents (Medical) associated with MISSION: CURE INC.

Login to view more data

100 Deals associated with MISSION: CURE INC.

Login to view more data

100 Translational Medicine associated with MISSION: CURE INC.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 17 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

1

Login to view more data